Open access
Aug 2026
Surface and global proteomics identify ROR2 and other proteins as potentially actionable immunotherapeutic targets in osteosarcoma
This study analyzes the surfaceomes and global proteomes of 22 unique OS patient-derived xenografts (PDXs) using mass spectrometry to identify surface proteins for potential immunotherapeutic targeting and identifies several poorly characterized targets, including ROR2 and TMEM119.
Brian Mooney, Xiaojie Chu, G. Negri et al.
· Cell Reports · 0 citations